WisdomTree BioRevolution FundCboe Consolidated Listings:WDNA
- LAST PRICE14.79
- TODAY'S CHANGE (%)-0.61 (-3.96%)
- Bid / Lots7.40/ 1
- Ask / Lots22.20/ 2
- Open / Previous Close14.79 / 15.40
- Day Range
- 52 Week Range
- Volume323
- Overall Morningstar Rating2 out of 5 Starsout of 268 funds
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
Daily Premium/Discount
| Date | Daily Premium/Discount |
|---|---|
| 08/20/2024 | 0.06% |
| 08/21/2024 | -0.04% |
| 08/22/2024 | -0.10% |
| 08/23/2024 | -0.05% |
| 08/26/2024 | -0.08% |
| 08/27/2024 | -0.04% |
| 08/28/2024 | -0.02% |
| 08/29/2024 | -0.08% |
| 08/30/2024 | -0.11% |
| 09/03/2024 | -0.16% |
| 09/04/2024 | -0.04% |
| 09/05/2024 | -0.19% |
| 09/09/2024 | -0.11% |
| 09/10/2024 | -0.05% |
| 09/11/2024 | 0.01% |
| 09/12/2024 | -0.09% |
| 09/13/2024 | -0.13% |
| 09/16/2024 | 0.07% |
| 09/17/2024 | -0.06% |
| 09/18/2024 | 0.09% |
| 09/19/2024 | -0.16% |
| 09/20/2024 | -0.17% |
| 09/23/2024 | -0.06% |
| 09/24/2024 | -0.12% |
| 09/25/2024 | -0.16% |
| 09/26/2024 | -0.19% |
| 09/27/2024 | -0.16% |
| 09/30/2024 | -0.10% |
| 10/01/2024 | -0.04% |
| 10/02/2024 | 0.05% |
| 10/03/2024 | 0.03% |
| 10/04/2024 | 0.05% |
| 10/07/2024 Largest Discount | -0.20% |
| 10/08/2024 | 0.07% |
| 10/09/2024 | -0.06% |
| 10/10/2024 | 0.02% |
| 10/11/2024 | -0.05% |
| 10/14/2024 | -0.08% |
| 10/15/2024 | -0.04% |
| 10/16/2024 | -0.02% |
| 10/17/2024 | 0.03% |
| 10/18/2024 | 0.07% |
| 10/21/2024 | -0.02% |
| 10/22/2024 | 0.07% |
| 10/23/2024 | 0.02% |
| 10/24/2024 | 0.08% |
| 10/25/2024 | -0.05% |
| 10/28/2024 | 0.05% |
| 10/29/2024 | 0.03% |
| 10/30/2024 | -0.02% |
| 10/31/2024 | 0.17% |
| 11/01/2024 | -0.12% |
| 11/04/2024 | -0.06% |
| 11/05/2024 | -0.05% |
| 11/06/2024 | -0.15% |
| 11/07/2024 | 0.05% |
| 11/08/2024 | -0.02% |
| 11/11/2024 | 0.00% |
| 11/12/2024 | 2.96% |
| 11/13/2024 | 0.03% |
| 11/14/2024 | -0.04% |
| 11/15/2024 Largest Premium | 4.25% |
| US Stock | 84.2% |
|---|---|
| Non-US Stock | 15.8% |
| Cash | 0 |
| Convertible | 0 |
| Non-US Bond | 0 |
| Other | 0 |
| Healthcare | 83.4% |
|---|---|
| Basic Mat. | 11.6% |
| Consumer Defensive | 3.8% |
| Consumer Cyclical | 0.7% |
| Communication Services | 0 |
| Energy | 0 |
| Financial Serv.s | 0 |
| Industrials | 0 |
| Real Estate | 0 |
| Technology | 0 |
| Utilities | 0 |
| United States | 84.2% |
|---|---|
| Europe | 5.0% |
| Asia/Oceania | 2.0% |
| Canada | 0.8% |
| Africa | 0 |
| Latin America | 0 |
| Company Name sortable | Position sortable | Allocation sortable | Allocation sortable1 Month Change | Market Value sortable |
|---|---|---|---|---|
Twist Bioscience Corp | Long | 3.0% | 0.00% | $68.8K |
Natera Inc | Long | 2.8% | 0.00% | $65.3K |
Novonesis (Novozymes) B Class B | Long | 2.8% | 0.00% | $64.7K |
Geron Corp | Long | 2.4% | 0.00% | $55.5K |
Agios Pharmaceuticals Inc | Long | 2.3% | 0.00% | $53.8K |
Eli Lilly and Co | Long | 2.3% | 0.00% | $53.1K |
Blueprint Medicines Corp | Long | 2.3% | 0.00% | $52.6K |
Iovance Biotherapeutics Inc | Long | 2.1% | 0.00% | $49.5K |
Vericel Corp | Long | 2.0% | 0.00% | $46.6K |
Veracyte Inc | Long | 1.9% | 0.00% | $44.5K |
Reports
- ManagedInvestmentETF11/10/24
Morningstar ETF Report
The Morningstar ETF Report offers in-depth analyst research on exchange-traded funds to help you evaluate these investments and how they fit within a portfolio.
Morningstar Ratings
| Time Horizon | Star Rating |
|---|---|
| Overall Rating | 2 out of 5 Stars |
| 3 Year Rating | 2 out of 5 Stars |
| 5 Year Rating | Not Rated |
| 10 Year Rating | Not Rated |
Past performance is no guarantee of future results. The ratings reflect historical risk-adjusted performance, and the overall rating is derived from a weight average of the fund's 3, 5, and 10 year (Morningstar Rating) metrics.
Style Box is calculated only using the long position holdings of the portfolio.
Best Fit Index | WisdomTree BioRevolution USD |
|---|---|
Category | |
Sponsor | WisdomTree Asset Management Inc |
Inception | June 1, 2021 |
The investment seeks to track the price and yield performance, before fees and expenses, of the WisdomTree BioRevolution Index (“indexâ€). The fund generally uses a representative sampling strategy to achieve its investment objective, meaning it generally will invest in a sample of the securities in the index whose risk, return and other characteristics resemble the risk, return and other characteristics of the index as a whole. The index is designed to provide exposure to equity securities of exchange listed companies globally that will be significantly transformed by advancements in genetics and biotechnology. The fund is non-diversified.
| Total Net Assets | $2.3M |
|---|---|
| Shares Out. | 150.0K |
| Net Asset Value (NAV) | $14.77 |
| Prem/Discount to NAV | 4.25% |
| P/E Ratio | --- |
| Dividend Yield | 0.91% |
| Dividend per Share | 0.14 USD |
| Ex-Dividend Date | 12/22/2023 |
| Dividend Payment Date | 12/28/2023 |
| Beta | --- |
| Morningstar Investment Style | Health |
| Equity Style | Mid Cap Blend |
| Credit Quality / Duration | --- |
| Actual Management Fee | 0.45% |
|---|---|
| Actual Mgmt. Expense Ratio (MER) | 0.45% |